We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008) (ASPECT-NP)

This study is currently recruiting participants.
Verified November 2017 by Cubist Pharmaceuticals LLC
Sponsor:
ClinicalTrials.gov Identifier:
NCT02070757
First Posted: February 25, 2014
Last Update Posted: November 22, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Cubist Pharmaceuticals LLC
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 19, 2018
  Estimated Primary Completion Date: May 28, 2018 (Final data collection date for primary outcome measure)
Publications: